Press release
Ovarian Cancer Drug Market Focusing on Top Companies and Industry Overview 2026|F. Hoffmann-La Roche Ltd, Pfizer Inc., Merck KGaA, Syndax, Clovis Oncology
Ovarian Cancer Drug Market
Ovarian cancer drug market is rise gradually to an estimated value of USD 5.6 Billion by 2026 substantial CAGR of 20.1% in the forecast period of 2019-2026. Rising incidence of ovarian cancer, growing geriatric population and robust drug pipeline for treating ovarian cancer are the key factors for enhancing the market growth.
Download Sample PDF Copy of Report https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-ovarian-cancer-drug-market&pm
Few of the major competitors currently working in the ovarian cancer market are Allergan Plc, AstraZeneca, F. Hoffmann-La Roche Ltd, Pfizer Inc., Merck KGaA, Syndax, Clovis Oncology, Boehringer Ingelheim International GmbH, GlaxoSmithKline plc, Exelixis, Inc., DelMar Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Novartis AG, Johnson & Johnson Services, Inc., AbbVie Inc., Oasmia Pharmaceutical AB, TESARO, Inc., Amgen, Inc., and among others.
Market Drivers
Increase in prevalence rate of ovarian cancer worldwide
Rising awareness about treatment and technological advancement is driving the growth of market
Increase in the rate of R&D initiatives is driving ovarian cancer therapeutics market
Market Restraints
High cost involved in the treatment
Patent expiry from many companies and introduction of generic drugs is expected to restrain the growth if the market
Lack of awareness among the patient and physician about ovarian treatment
Key Developments in the Market:
In June 2018, Hoffmann-La Roche Ltd got FDA approval for Avastin (bevacizumab) in combination with chemotherapy for patients with epithelial ovarian, fallopian tube and primary peritoneal cancer. Avastin is indicated previously for treatment of advanced colorectal cancer in 2004. This discovery of new indication achieved the advancing therapeutics in areas of unmet need.
In April 2018, Clovis Oncology got FDA approval for Rubraca (rucaparib) in the United States for the maintenance treatment of adult patient with epithelial ovarian cancer and fallopian tube cancer which were previously on platinum-based chemotherapy.
Inquire Regarding This Report https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-ovarian-cancer-drug-market&pm
Segmentation: Global Ovarian Cancer Drug Market
By Type
Epithelial Ovarian Cancer
Germ Cell Ovarian Tumor
Sex Cord Stromal Tomours
Borderline Ovarian Tumour
Others
By Drug Type
Alkylating Agents
Mitotic Inhibitors
Carboplatin
Cisplatin
Docetaxel
Paclitaxel
Vegfr Inhibitor
Parp Inhibitors
Niraparib
Rucaparib
Bevacizumab
Olaparib
Doxorubicin Hcl Liposome Injection
Others
By Treatment
Medication
Chemotherapy
Radiation Therapy
Hormone Therapy
Surgery
By Route Of Administration
Oral
Injectable
By End Users
Hospitals
Homecare
Specialty Clinics
Others
By Geography
North America
South America
Europe
Asia-Pacific
Middle East & Africa
For More Insights Get Detailed TOC https://www.databridgemarketresearch.com/toc/?dbmr=global-ovarian-cancer-drug-market&pm
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Corporatesales@databridgemarketresearch.com
About Data Bridge Market Research
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ovarian Cancer Drug Market Focusing on Top Companies and Industry Overview 2026|F. Hoffmann-La Roche Ltd, Pfizer Inc., Merck KGaA, Syndax, Clovis Oncology here
News-ID: 1980387 • Views: …
More Releases from Data Bridge Market Research
"Trends and Forecast for the Syringes Market up to 2029"
"The global Syringes Market survey report endows with the basic information about industry, definition, classification, application, industry chain structure, industry overview and international market analysis. This industry analysis report explains market analysis based on regional, local as well as global level. The research studies of this market document helps to evaluate several important parameters that can be mentioned as investment in a rising market, success of a new product,…
Trends and Forecast for the Non-24-Hour Sleep-Wake Disorder Drug Market up to 20 …
"The large scale Non-24-Hour Sleep-Wake Disorder Drug Market report encompasses thorough analysis of Non-24-Hour Sleep-Wake Disorder Drug Market industry with respect to several factors that range from market drivers, market restraints, market segmentation, opportunities, challenges, and market revenues to competitive analysis. Furthermore, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report. It is the top-notch market research report generated…
Thoracic Outlet Syndrome Market Exhibit a Remarkable CAGR 5.30% Size, Share, Tre …
Explore Further Details about This Research Thoracic Outlet Syndrome Market Report https://www.databridgemarketresearch.com/reports/global-thoracic-outlet-syndrome-market
Market Analysis and Insights Thoracic Outlet Syndrome Market
Thoracic outlet syndrome market is expected to gain market growth in the forecast period of 2022-2029. Data Bridge Market Research analyses the market to account to grow at a CAGR of 5.30% in the above mentioned forecast period.
Thoracic outlet syndrome (TOC) is a collection of illnesses that produce numbness and tingling in the…
Automotive Air Conditioning (AC) Compressor Market Exhibit a Remarkable CAGR 3.8 …
Market Analysis and Insights of Automotive Air Conditioning (AC) Compressor Market
Automotive air conditioning (AC) compressor market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses the market will rise to USD 11,673.8 million by 2029 and to grow at a CAGR of 3.80% in the above-mentioned forecast period.
Explore Further Details about This Research Automotive Air Conditioning (AC) Compressor Market Report https://www.databridgemarketresearch.com/reports/global-automotive-air-conditioning-ac-compressor-market
Air conditioning systems…
More Releases for Ovarian
Polycystic Ovarian Syndrome Treatment Market Report
The findings reviewed by GME stated that the Global Polycystic Ovarian Syndrome Treatment Market will expand with a CAGR value of 5.2 percent from 2021 to 2026. The rising incidence of PCOS increased understanding among a group of patients, and the growing acceptance of standard treatment boosts the PCOS treatment industry growth over the projected timeframe. Furthermore, the research and development of PCOS are predicted to aid in market growth.
Browse…
How deadly is Ovarian Cancer?
Ovarian Drugs and Treatment Market describes its growth, size, share, Forecast and trends to 2025
Ovarian cancer is a cancer that forms in or on an ovary. It results in abnormal cells that have the ability to invade or spread to other parts of the body.
The global Ovarian Cancer Treatment Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025,…
Polycystic Ovarian Syndrome - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Polycystic Ovarian Syndrome - Pipeline Review, H2 2017 to its growing collection of premium market research reports.
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Polycystic Ovarian Syndrome - Pipeline Review, H2 2017, provides an overview of the Polycystic Ovarian Syndrome (Women's Health) pipeline landscape.
Polycystic ovary syndrome (PCOS) is a common hormonal disorder among women of reproductive age. Symptoms…
Ovarian Cancer Drugs Market Report : 2017
Reports And Markets Publish a New Market Research Report On –"Ovarian Cancer Drugs Market Report : 2017"
Access Full Report With Table Of Contents @ https://www.reportsandmarkets.com/reports/united-states-ovarian-cancer-drugs-market-report-2017-1541150
In this report, the United States Ovarian Cancer Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report splits the United…
Ovarian Cancer - Pipeline Review, H1 2017
Report Hive Market Research Released a New Research Report of 2027 pages on Title " Ovarian Cancer - Pipeline Review, H1 2017 "with detailed Analysis, Forecast and Strategies.
Ovarian Cancer - Pipeline Review, H1 2017
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer - Pipeline Review, H1 2017, provides an overview of the Ovarian Cancer (Oncology) pipeline landscape.
Ovarian cancer is any cancerous growth that may occur in different…
Ovarian Cancer - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Ovarian Cancer - Heat Map and Analysis to its growing collection of premium market research reports.
Ovarian Cancer (OC) is the fifth most common malignancy diagnosed in women, and the most common gynecological cancer, with an estimated 225,000 new cases diagnosed globally in 2008. Rates are particularly high in developed countries, and especially in Northern Europe. However, substantial improvements in…
